Joshua Reed - Insider Trading & Ownership

Entity
Individual
Location
C/O Aldeyra Therapeutics, Inc., 131 Hartwell Avenue, Suite 320, Lexington, Massachusetts
Summary
The estimated net worth of Joshua Reed is at least $599 K dollars as of July 1, 2024. Joshua Reed is the Chief Financial Officer of Aldeyra Therapeutics, Inc. and owns shares of Aldeyra Therapeutics, Inc. (ALDX) stock worth about $478 K. Joshua Reed is the Director of Scholar Rock Holding Corp and owns shares of Scholar Rock Holding Corp (SRRK) stock worth about $121 K.
All Insider Reports
All Insider Reports

Ownership of Joshua Reed

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALDX Aldeyra Therapeutics, Inc. Chief Financial Officer $478 K Mar 30, 2022
SRRK Scholar Rock Holding Corp Director $121 K Jun 27, 2024
OMGA Omega Therapeutics, Inc. Chief Financial Officer Feb 7, 2024

Insider Transactions Reported by Joshua Reed:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership